We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of STA-1 as an Add-on Treatment to Donepezil

This study is not yet open for participant recruitment.
Verified August 2014 by Sinphar Pharmaceutical Co., Ltd
Sponsor:
ClinicalTrials.gov Identifier:
NCT01255046
First Posted: December 7, 2010
Last Update Posted: August 20, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Information provided by (Responsible Party):
Sinphar Pharmaceutical Co., Ltd
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Study Completion Date: No date given
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)